Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 'Contrast agents' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Contrast agents' found in 17 terms [] and 118 definitions []
previous     76 - 80 (of 135)     next
Result Pages : [1 2 3 4]  [5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... ]
Searchterm 'Contrast agents' was also found in the following services: 
spacer
News  (49)  Resources  (7)  Forum  (8)  
 
Dy-DOTA-4AmCEInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Short name: Dy-DOTA-4AmCE, central moiety: Dy2+, contrast effect: T2*enhanced
Dy-DOTA-4AmCE, a macrocyclic complex is characterized by a very slow water exchange, a complex compared with several Dy-DTPA derivatives known for their efficacy as T2 contrast agents at high magnetic fields.
spacer
 
Further Reading:
  Basics:
Dysprosium
   by www.scescape.net    
Searchterm 'Contrast agents' was also found in the following services: 
spacer
Radiology  (46) Open this link in a new windowUltrasound  (75) Open this link in a new window
DyamideInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.
 
Some dyamides are under preclinical development as intravascular MRI contrast agents for blood flow perfusion.

Short name: Dy-DTPA-BMA, generic name: Sprodyamide, central moiety: Dy2+, contrast effect: T2*enhanced, relaxivity: r1=3.4, r2=3.8, B0=0.47,

Short name: Dy-DTPA, central moiety: Dy2+, contrast effect: T2*enhanced,

Short name: Albumin-(Dy-DTPA)x, central moiety: Dy2+, contrast effect: T2*enhanced.
spacer
 
Further Reading:
  Basics:
Dysprosium
   by www.scescape.net    
MRI Resources 
Spectroscopy pool - MRCP - MRI Technician and Technologist Schools - Online Books - Education - Sequences
 
Fast Imaging with Steady PrecessionInfoSheet: - Sequences - 
Intro, 
Overview, 
Types of, 
etc.
 
(TrueFISP) True fast imaging with steady state precession is a coherent technique that uses a fully balanced gradient waveform. The image contrast with TrueFISP is determined by T2*//T1 properties and mostly depending on TR. The speed and relative motion insensitivity of acquisition help to make the technique reliable, even in patients who have difficulty with holding their breath.
Recent advances in gradient hardware have led to a decreased minimum TR. This combined with improved field shimming capabilities and signal to noise ratio, has allowed TrueFISP imaging to become practical for whole-body applications. There's mostly T2* weighting. With the used ultrashort TR-times T1 weighting is almost impossible. One such application is cardiac cine MR with high myocardium-blood contrast. Spatial and temporal resolution can be substantially improved with this technique, but contrast on the basis of the ratio of T2* to T1 is not sufficiently high in soft tissues. By providing T1 contrast, TrueFISP could then document the enhancement effects of T1 shortening contrast agents. These properties are useful for the anatomical delineation of brain tumors and normal structures. With an increase in SNR ratio with minimum TR, TrueFISP could also depict the enhancement effect in myoma uteri. True FSIP is a technique that is well suited for cardiac MR imaging. The imaging time is shorter and the contrast between the blood and myocardium is higher than that of FLASH.

See Steady State Free Precession.
 
Images, Movies, Sliders:
 Cardiac Infarct 4 Chamber Cine 1  Open this link in a new window
    
 
spacer

• View the DATABASE results for 'Fast Imaging with Steady Precession' (3).Open this link in a new window

 
Further Reading:
  Basics:
Accurate T1 Quantification Using a Breath-hold Inversion Recovery TrueFISP Sequence
2003   by rsna2003.rsna.org    
Searchterm 'Contrast agents' was also found in the following services: 
spacer
News  (49)  Resources  (7)  Forum  (8)  
 
Ferric Ammonium CitrateInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.
 
Ferric ammonium citrate is a complex salt of indefinite composition that contains varying amounts of iron, that is obtained as red crystals or a brownish yellow powder or as green crystals or powder, and that was used formerly in medicine for treating iron-deficiency anaemia.
Solutions (e.g. corn oil emulsion) of ferric ammonium citrate (e.g., FerriSeltz, Geritol) can be used as positive oral contrast agents in MRI. Ferric ammonium citrate is safe and effective in humans, but has minor side effects.

See also Classifications, Characteristics, etc.
spacer

• View the DATABASE results for 'Ferric Ammonium Citrate' (5).Open this link in a new window

Searchterm 'Contrast agents' was also found in the following services: 
spacer
Radiology  (46) Open this link in a new windowUltrasound  (75) Open this link in a new window
FerristeneInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.
 
Ferristene is a superparamagnetic agent that has been used as a magnetic iron particle solution for gastrointestinal use as a negative contrast agent with 23.4 Fe/200ml required concentration.

See also Abdoscan®, Oral Contrast Agents.
spacer

• View the DATABASE results for 'Ferristene' (3).Open this link in a new window

MRI Resources 
Cochlear Implant - - Implant and Prosthesis pool - Equipment - Directories - Cardiovascular Imaging
 
previous      76 - 80 (of 135)     next
Result Pages : [1 2 3 4]  [5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... ]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



MRI is trending to low field magnets :
reduced costs will lead to this change 
AI will close the gap to high field 
only in remote areas 
is only temporary 
never 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 3 December 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]